Peptide research
ARA-290
ARA-290 is a research-grade synthetic peptide derived from the three-dimensional structure of erythropoietin (EPO).
01 / Overview
Understanding ARA-290
ARA-290 is a research-grade synthetic peptide derived from the three-dimensional structure of erythropoietin (EPO). It has been developed as a peptide analogue for laboratory investigations involving the innate repair receptor (IRR), a receptor complex distinct from the homodimeric erythropoietin receptor responsible for erythropoiesis. This distinction has made ARA-290 an important investigational tool in receptor-specific research.
In experimental models, ARA-290 has been studied for its interaction with innate repair receptor signaling pathways and cellular response mechanisms associated with tissue stress and recovery. Researchers utilize ARA-290 to examine receptor-selective peptide signaling, cellular communication, and downstream molecular pathways under controlled laboratory conditions. Its receptor specificity has enabled investigations into biological processes separate from those traditionally associated with erythropoietin-mediated red blood cell production.
As a structurally engineered peptide analogue, ARA-290 continues to be widely employed in laboratory studies focused on receptor biology, peptide-receptor interactions, and cellular signaling networks. Ongoing research seeks to further characterize the molecular mechanisms associated with innate repair receptor activation and peptide-mediated cellular communication.
This product is supplied strictly for laboratory research purposes only. Not for human consumption, clinical use, cosmetic use, or veterinary application. Further research is required to fully characterize its biological interactions.
Technical details
Composition, characteristics, and laboratory context.
- Peptide Name
- ARA-290
- Content
- 5 mg per vial
- Peptide Class
- Synthetic erythropoietin-derived peptide analogue (research grade)
- Primary Research Focus Areas
-
- Innate repair receptor (IRR) signaling studies
- Receptor-selective peptide investigations
- Cellular signaling pathway research
- Tissue stress-response models
- Research Characteristics
-
- Derived from the structural region of erythropoietin
- Studied for interaction with the innate repair receptor
- Investigated independently of erythropoietic receptor signaling
- Frequently utilized in receptor biology research
- Form
- Lyophilized peptide
- Purity
- ≥98% (HPLC) (per COA)
- Storage
- Store frozen under recommended laboratory conditions; protect from light and moisture
- Handling
- For qualified laboratory personnel only
- Regulatory Status
-
- Research Use Only (RUO)
- Not approved for human or animal use
- Not intended to diagnose, treat, cure, or prevent any disease
Research at a glance
| Feature | Erythropoietin (EPO) | EPO-Derived Peptide Analogues | ARA-290 |
|---|---|---|---|
| Structure Type | Full-length glycoprotein | Peptide analogue | Synthetic EPO-derived peptide |
| Primary Research Focus | EPO receptor biology | Receptor-specific investigations | Innate repair receptor signaling |
| Research Target | Multiple EPO receptor interactions | Selected receptor pathways | Innate repair receptor (IRR) |
| Cellular Signaling Studies | Yes | Yes | Primary research focus |
| Intended Use | Laboratory research only | Laboratory research only | Laboratory research only |
Important: This comparison reflects structural and research-focus differences only and does not indicate biological outcomes or medical relevance.
Questions, answered.
What is ARA-290?
ARA-290 is a synthetic peptide derived from the structure of erythropoietin (EPO). It is investigated in laboratory research for its interaction with the innate repair receptor (IRR) and associated cellular signaling pathways.
What type of peptide is ARA-290?
ARA-290 is an erythropoietin-derived peptide analogue designed for receptor-specific laboratory research. It represents a small region of the larger erythropoietin molecule rather than the complete protein.
What research areas commonly study ARA-290?
ARA-290 is examined in laboratory models related to: • Innate repair receptor signaling • Receptor-selective peptide interactions • Cellular communication pathways • Tissue stress-response mechanisms
How does ARA-290 differ from erythropoietin?
Unlike full-length erythropoietin, ARA-290 is a synthetic peptide analogue derived from a specific structural region of the parent protein and is investigated primarily for its interaction with the innate repair receptor rather than the classical erythropoietin receptor.
Is ARA-290 approved for medical, cosmetic, or clinical use?
No. ARA-290 is supplied strictly for laboratory research purposes and is not approved for human consumption, cosmetic application, clinical use, or veterinary use.
How should ARA-290 be stored?
ARA-290 should be stored frozen, protected from light and moisture, and handled according to standard laboratory peptide storage protocols.
Research use only
These products are intended strictly for laboratory research purposes. They are not for human consumption, clinical use, diagnostic use, or veterinary application. These products are not approved by any regulatory authority for medical use and are not intended to diagnose, treat, cure, or prevent any disease. All information provided is for educational and research reference purposes only. Proper laboratory handling procedures must be followed. The purchaser assumes full responsibility for the appropriate use, storage, and handling of this material.